Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness
Questions remain about the merits of asparaginase-based therapy
Radiation therapy produces anti-inflammatory response
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology
A retrospective analysis
Noninvasive treatment may slow progression of Dupuytren's disease and plantar fibromatrosis
Age alone should not rule out patients from potentially curative treatment
Reconsidering axillary lymph node dissection as well as depth of surgical margins
Researchers uncover profound differences in the mechanism of action between different PD-L1 checkpoint inhibitors
Advertisement
Advertisement